Filtros de búsqueda

Lista de obras de Luca Valenti

A 360-degree overview of paediatric NAFLD: recent insights.

artículo científico

A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease

artículo científico publicado en 2014

A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease

artículo científico

A new definition for metabolic associated fatty liver disease: an international expert consensus statement

artículo científico publicado en 2020

A novel alpha1-antitrypsin null variant (PiQ0Milano ).

artículo científico publicado en 2013

A population-based study on the prevalence of NASH using scores validated against liver histology

artículo científico publicado en 2013

A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis

artículo científico publicado en 2010

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.

scientific article published on March 2014

A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.

artículo científico publicado en 2010

AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement

scientific article published on 02 January 2020

Accuracy of imaging methods for steatohepatitis diagnosis in non-alcoholic fatty liver disease patients: A systematic review

artículo científico publicado en 2019

Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease.

artículo científico publicado en 2017

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

artículo científico publicado en 2021

Approach to the patient with chronic hepatitis B and decompensated cirrhosis

scientific article published on 01 February 2020

Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis

scientific article published on 29 April 2019

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease

artículo científico publicado en 2019

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

artículo científico publicado en 2005

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

artículo científico publicado en 2008

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

artículo científico publicado en 2014

Association of ABO blood group and secretor phenotype with severe COVID-19

scientific article published on 03 October 2020

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2010

Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology

artículo científico publicado en 2018

Building mass to prevent non-alcoholic fatty liver disease?

artículo científico publicado en 2019

CDKN1A: a double-edged sword in fatty liver?

artículo científico publicado en 2014

COVID-19 and liver disease

scientific article published on 06 April 2020

Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?

article

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

artículo científico publicado en 2008

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.

artículo científico publicado en 2017

Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth.

artículo científico publicado en 2013

Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis

artículo científico publicado en 2020

Circulating ghrelin levels in patients with inflammatory bowel disease

artículo científico publicado en 2006

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients ⬇️

artículo científico publicado el 9 de julio de 2013

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.

artículo científico publicado en 2012

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

artículo científico publicado en 2020

Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents

artículo científico publicado en 2019

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients

artículo científico publicado en 2004

DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.

artículo científico publicado en 2015

DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis

artículo científico publicado en 2015

Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis

artículo científico publicado en 2017

Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood

artículo científico publicado en 2016

Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease

artículo científico publicado en 2012

Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease

artículo científico publicado en 2013

Dietary iron overload induces visceral adipose tissue insulin resistance.

artículo científico publicado en 2013

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research

artículo científico publicado en 2018

Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps

artículo científico publicado en 2019

Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease

artículo científico publicado en 2010

Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is "fatty gut" involved in disease progression?

artículo científico publicado en 2017

Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance

artículo científico publicado en 2003

Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.

artículo científico publicado en 2012

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.

artículo científico publicado en 2016

FGF23 and Fetuin-A Interaction in the Liver and in the Circulation

artículo científico publicado en 2018

Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation

artículo científico publicado en 2008

FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage

scientific article published on 08 December 2018

Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2017

GENETICS AND EPIGENETICS IN THE CLINIC: PRECISION MEDICINE IN THE MANAGEMENT OF FATTY LIVER DISEASE

scientific article published on 22 January 2020

GNPAT p.D519G variant and iron metabolism during oral iron tolerance test.

artículo científico publicado en 2016

GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors

artículo científico publicado en 2017

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2012

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis

artículo científico publicado en 2015

Genetic Insight Into the Pathogenesis of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2014

Genetic insight into Covid-19 related liver injury

artículo científico publicado en 2020

Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology

scientific article published on 14 March 2020

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

artículo científico publicado en 2013

Genetic variants in the MTHFR are not associated with fatty liver disease

artículo científico publicado en 2020

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2010

Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers

scientific article published on 19 October 2019

Genetics and epigenetics of NAFLD and NASH: Clinical impact

artículo científico publicado en 2017

Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update

artículo científico publicado en 2018

Genetics of nonalcoholic fatty liver disease.

artículo científico

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort

artículo científico publicado en 2020

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

scientific article published on 17 June 2020

Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion.

artículo científico publicado en 2011

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2009

HFE mutations and iron in hemodialysis patients

artículo científico publicado en 2017

HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients

artículo científico publicado en 2009

HFEmutations in nonalcoholic fatty liver disease

scientific article published on 01 May 2008

Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload

article

Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs

artículo científico publicado en 2020

Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease

artículo científico publicado en 2018

Hepatic iron is the major determinant of serum ferritin in NAFLD patients

artículo científico publicado en 2017

Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.

artículo científico publicado en 2013

Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.

artículo científico publicado en 2014

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

artículo científico publicado en 2018

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

artículo científico publicado en 2014

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

artículo científico publicado en 2018

Hepcidin levels in chronic hemodialysis patients: a critical evaluation

artículo científico publicado en 2014

Hepcidin resistance in dysmetabolic iron overload

artículo científico publicado en 2016

High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload

artículo científico publicado en 2015

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2010

I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology

article

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

artículo científico publicado en 2010

IFNL4 rs368234815 TT>δG Variant is Associated with Liver Damage in Patients with Non-alcoholic Fatty Liver Disease

artículo científico publicado en 2017

IL28B rs12979860 polymorphism influences serum TNFalpha levels in chronic hepatitis C

artículo científico publicado en 2012

IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?

artículo científico publicado en 2011

Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia

scientific journal article

Impact of natural neuromedin-B receptor variants on iron metabolism

artículo científico publicado en 2019

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

artículo científico publicado en 2012

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

artículo científico publicado en 2008

Increased circulating adiponectin in males with chronic HCV hepatitis.

artículo científico publicado en 2015

Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.

artículo científico publicado en 2012

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis

artículo científico publicado en 2003

Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents

artículo científico publicado en 2014

Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis

scientific article published on 02 March 2020

Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease

artículo científico publicado en 2017

Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients

artículo científico publicado en 2012

Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.

artículo científico publicado en 2014

Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients

artículo científico publicado en 2014

Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.

artículo científico publicado en 2012

Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension

artículo científico publicado en 2015

Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver

artículo científico publicado en 2008

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

artículo científico publicado en 2007

Iron genes, dysmetabolism and fibrosis in chronic hepatitis C

article

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target ⬇️

artículo científico publicado el 28 de junio de 2011

Iron overload induces hypogonadism in male mice via extrahypothalamic mechanisms.

artículo científico publicado en 2017

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors

artículo científico publicado en 2014

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover

scientific article published on 06 April 2020

LPIN1 rs13412852 Polymorphism in Pediatric Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2012

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease

scientific article published on 01 January 2020

Liver International: Anticipating the future of hepatology worldwide

artículo científico publicado en 2019

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

artículo científico publicado en 2017

Liver fat accumulation is associated with circulating PCSK9

artículo científico publicado en 2016

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

artículo científico publicado en 2020

Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis

artículo científico publicado en 2012

MAFLD vs NAFLD: Let the contest begin!

scientific article published on 01 September 2020

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.

artículo científico publicado en 2017

MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2015

Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis

scientific article published on 12 December 2019

Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease

artículo científico publicado en 2012

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes

scientific article published on 12 February 2020

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

artículo científico publicado en 2017

Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C

scientific article published on 01 December 2011

Mutant PNPLA3 I148M protein as pharmacological target for liver disease

artículo científico publicado en 2017

NAFLD in children: new genes, new diagnostic modalities and new drugs

scientific article published on 05 July 2019

NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?

Nonalcoholic Fatty Liver Disease in Children.

artículo científico publicado en 2018

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes

artículo científico publicado en 2005

Nutritional therapy for nonalcoholic fatty liver disease.

artículo científico publicado en 2015

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.

artículo científico publicado en 2015

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients

scientific article published on 27 March 2019

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

artículo científico publicado en 2020

PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.

artículo científico publicado en 2015

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2013

PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity

artículo científico publicado en 2015

PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings

scientific article published on 03 March 2020

PNPLA3 I148M polymorphism and liver damage in obese children

article

PNPLA3 I148M polymorphism and progressive liver disease

artículo científico publicado en 2013

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

artículo científico publicado en 2013

PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.

artículo científico

PNPLA3 Ile148Met variant and hepatocellular carcinoma: a matter of fat

artículo científico publicado en 2012

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

artículo científico publicado en 2014

PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis

artículo científico publicado en 2016

Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.

artículo científico publicado en 2015

Particulate matter phagocytosis induces tissue factor in differentiating macrophages

artículo científico publicado en 2015

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

artículo científico publicado en 2011

Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantation

scientific article published on 01 October 2011

Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

artículo científico publicado en 2012

Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.

artículo científico publicado en 2013

Pathophysiology of Non Alcoholic Fatty Liver Disease

artículo científico publicado en 2016

Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?

artículo científico publicado en 2013

Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors

artículo científico publicado en 2010

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

Post-transplant metabolic syndrome in children: Know better to cure better

scientific article published on 21 February 2019

Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial

scientific article published on 23 July 2019

Prevalence and 9-year incidence of hepatitis E virus infection among North Italian blood donors: Estimated transfusion risk

scientific article published on 20 March 2020

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

scientific article published on 29 January 2019

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.

artículo científico publicado en 2016

Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis.

artículo científico publicado en 2016

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease

artículo científico publicado en 2018

RETRACTION: Turning up the heat in the fat cell

artículo científico publicado en 2005

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

Redefining fatty liver disease classification in 2020

scientific article published on 01 May 2020

Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease

artículo científico publicado en 2016

Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells.

artículo científico publicado en 2000

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis

artículo científico publicado en 2007

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2016

Reply

artículo científico publicado en 2015

Reply

artículo científico publicado en 2014

Reply to "Statin treatment for non-alcoholic steatohepatitis"

scientific article published on 08 October 2015

Reply: To PMID 25251399

artículo científico publicado en 2015

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

artículo científico publicado en 2010

Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease

artículo científico publicado en 2014

Role of iron in hepatocellular carcinoma

artículo científico publicado en 2014

SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak

scientific article published on 18 May 2020

Searching for coeliac disease in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2004

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

artículo científico publicado en 2010

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

scientific article published on 26 June 2019

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2010

Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach

artículo científico publicado en 2010

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between <scp>ChatGPT</scp> and the editors of <i>Liver International</i>

artículo científico publicado en 2023

Statin use and non-alcoholic steatohepatitis in at risk individuals

artículo científico publicado en 2015

Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis

artículo científico publicado en 2017

Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study

artículo científico publicado en 2019

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

artículo científico publicado en 2005

TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda

artículo científico publicado en 2003

TNFalpha promoter polymorphisms.

artículo científico publicado en 2004

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2017

Telomeres, NAFLD and Chronic Liver Disease

artículo científico publicado en 2016

Telomeric zinc-finger associated protein (TZAP): a new player in telomere diseases?

artículo científico publicado en 2017

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease

artículo científico publicado en 2012

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

artículo científico publicado en 2013

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

artículo científico publicado en 2011

The I148M Variant of PNPLA3 Reduces the Response to Docosahexaenoic Acid in Children with Non-Alcoholic Fatty Liver Disease

article

The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation

artículo científico publicado en 2021

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

artículo científico publicado en 2016

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

scientific article published on 12 July 2011

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

artículo científico publicado en 2019

The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.

artículo científico publicado en 2014

The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.

artículo científico publicado en 2017

The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis.

artículo científico publicado en 2004

The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?

artículo científico publicado en 2015

The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage

artículo científico publicado en 2016

Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients

artículo científico publicado en 2015

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

artículo científico publicado en 2015

Treatment choices for people infected with HCV.

artículo científico publicado en 2004

Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF)

artículo científico publicado en 2014

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

artículo científico publicado en 2002

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis

artículo científico publicado en 2001

Uncovering occult hepatitis B in blood donations: a tale of two worlds

scientific article published on 01 November 2019

Uncovering the genetics of cirrhosis: New plots for the usual suspects

scientific article published on 01 February 2020

Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis

artículo científico publicado en 2020

Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms

article

Update on NAFLD genetics: From new variants to the clinic

scientific article published on 04 March 2020

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study

artículo científico publicado en 2010

Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning

scientific article published on 04 February 2020

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

artículo científico publicado en 2003

Whole exome sequencing for personalized hepatology: Expanding applications in adults and challenges

artículo científico publicado en 2019

mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance

artículo científico publicado en 2019

myVCF: a desktop application for high-throughput mutations data management.

artículo científico publicado en 2017

β-Klotho gene variation is associated with liver damage in children with NAFLD

scientific article published on 23 October 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda